VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
BEATHeartBeam, Inc.
$0.76$26M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

BEAT logoHeartBeam, Inc.(BEAT)Earnings, Financials & Key Ratios

BEAT•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryHealthcare ITSub-IndustryVirtual Care and Digital Programs
AboutHeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.Show more
  • Revenue$0
  • EBITDA-$21M-6.1%
  • Net Income-$21M-8.1%
  • EPS (Diluted)-0.62+15.1%
  • ROE-987.32%-346.5%

BEAT Key Insights

HeartBeam, Inc. (BEAT) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

  • ✗Profits declining 81.5% over 5 years
  • ✗Weak Piotroski F-Score: 1/9
  • ✗Weak momentum: RS Rating 11 (bottom 11%)
  • ✗Shares diluted 26.5% in last year
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when BEAT posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

BEAT Price & Volume

HeartBeam, Inc. (BEAT) stock price & volume — 10-year historical chart

Loading chart...

BEAT Growth Metrics

HeartBeam, Inc. (BEAT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM0.47%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM22.97%

Return on Capital

10 Years-172.18%
5 Years-320.92%
3 Years-462.17%
Last Year-993.14%

BEAT Recent Earnings

HeartBeam, Inc. (BEAT) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 0/12 qtrs (0%)
Q2 2026Latest
May 13, 2026
Metric
Actual
Est
EPS
$0.12+14.3%
$0.14
Rev
$100,000-33.2%
$149,750
Q2 2026
Mar 12, 2026
Metric
Actual
Est
EPS
$0.14-7.7%
$0.13
Rev
—
$1M
Q4 2025
Nov 13, 2025
Metric
Actual
Est
EPS
$0.15+6.3%
$0.16
Rev
—
$875,000
Q3 2025
Aug 13, 2025
Metric
Actual
Est
EPS
$0.15+6.3%
$0.16
Rev
—
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 13, 2026
$0.12vs $0.14+14.3%
$100,000vs $149,750-33.2%
Q2 2026Mar 12, 2026
$0.14vs $0.13-7.7%
—vs $1M
Q4 2025Nov 13, 2025
$0.15vs $0.16+6.3%
—vs $875,000
Q3 2025Aug 13, 2025
$0.15vs $0.16+6.3%
—
Based on last 12 quarters of dataView full earnings history →

BEAT Peer Comparison

HeartBeam, Inc. (BEAT) competitors in Virtual Care and Digital Programs — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
AIRT logoAIRTAir T, Inc.Direct Competitor70.08M23.13-10.371.75%-2.48%-114.63%23.32
HSDT logoHSDTSolana CompanyDirect Competitor94.59M1.62-0.8810.57%-14.27%-155.31%
IDXX logoIDXXIDEXX Laboratories, Inc.Direct Competitor44.64B562.0942.9710.42%24.63%70.87%0.67
IRTC logoIRTCiRhythm Technologies, Inc.Direct Competitor3.44B104.65-75.2926.24%-3.53%-20.6%4.79
BFLY logoBFLYButterfly Network, Inc.Direct Competitor2.33B8.90-28.7118.96%-73.63%-36.79%0.10
GMED logoGMEDGlobus Medical, Inc.Direct Competitor10.69B79.2320.2116.65%18.92%13.04%0.03
LIVN logoLIVNLivaNova PLCProduct Competitor4.31B78.50-17.6410.74%7.47%9.13%0.39
NVCR logoNVCRNovoCure LimitedProduct Competitor1.62B14.28-11.708.28%-25.66%-50.82%0.85

Compare BEAT vs Peers

HeartBeam, Inc. (BEAT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs AIRT

Most directly comparable listed peer for BEAT.

Scale Benchmark

vs ABT

Larger-name benchmark to compare BEAT against a more recognizable public peer.

Peer Set

Compare Top 5

vs AIRT, HSDT, IDXX, IRTC

BEAT Income Statement

HeartBeam, Inc. (BEAT) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
286.78M399.47M00000000
Revenue Growth %
37.65%39.3%-100%-------
Cost of Goods Sold
114.41M148.99M000000024K
COGS % of Revenue
39.89%37.3%--------
Gross Profit
172.37M▲ 0%
250.49M▲ 45.3%
0▼ 100.0%
0▲ 0%
0▲ 0%
0▲ 0%
0▲ 0%
0▲ 0%
0▲ 0%
-24K▲ 0%
Gross Margin %
60.11%62.7%--------
Gross Profit Growth %
33.16%45.32%-100%-------
Operating Expenses
135.02M166.48M294K788K2.29M13.03M15.31M19.89M21.14M20.33M
OpEx % of Revenue
47.08%41.68%--------
Selling, General & Admin
123.92M155.28M253K655K2.03M7.35M8.52M8.84M7.69M8M
SG&A % of Revenue
43.21%38.87%--------
Research & Development
11.1M11.21M41K133K255K5.68M6.8M11.05M13.45M12.33M
R&D % of Revenue
3.87%2.81%--------
Other Operating Expenses
0000000000
Operating Income
37.35M▲ 0%
84M▲ 124.9%
-294K▼ 100.3%
-788K▼ 168.0%
-2.29M▼ 190.0%
-13.03M▼ 470.3%
-15.31M▼ 17.5%
-19.89M▼ 29.9%
-21.14M▼ 6.3%
-20.35M▲ 0%
Operating Margin %
13.02%21.03%--------
Operating Income Growth %
4.15%124.91%-100.35%-168.03%-189.97%-470.28%-17.52%-29.86%-6.3%-
EBITDA
65.91M124.17M00-2.29M00-19.88M-21.1M-20.3M
EBITDA Margin %
22.98%31.08%--------
EBITDA Growth %
31.47%88.39%-100%--100%---6.13%1.47%
D&A (Non-Cash Add-back)
28.56M40.17M294K788K013.03M15.31M7K40K57K
EBIT
-5.5M50.93M-294K-788K-2.29M-12.96M-14.64M-19.89M-21.14M-20.35M
Net Interest Income
00-242K-280K-2.16M0675K446K122K120K
Interest Income
00002.17K66K675K446K122K120K
Interest Expense
4.9M9.43M242K280K2.17M66K0000
Other Income/Expense
-47.75M-42.5M-242K-280K-2.14M69K675K439K124K122K
Pretax Income
-10.4M▲ 0%
41.5M▲ 499.2%
-536K▼ 101.3%
-1.07M▼ 99.3%
-4.43M▼ 314.6%
-12.96M▼ 192.7%
-14.64M▼ 12.9%
-19.45M▼ 32.9%
-21.02M▼ 8.1%
-20.23M▲ 0%
Pretax Margin %
-3.63%10.39%--------
Income Tax
6.75M-370K00000000
Effective Tax Rate %
-64.9%-0.89%0%0%0%0%0%0%0%0%
Net Income
-15.96M▲ 0%
42.82M▲ 368.4%
-536K▼ 101.3%
-1.07M▼ 99.3%
-4.43M▼ 314.6%
-12.96M▼ 192.7%
-14.64M▼ 12.9%
-19.45M▼ 32.9%
-21.02M▼ 8.1%
-20.23M▲ 0%
Net Margin %
-5.56%10.72%--------
Net Income Growth %
-129.86%368.36%-101.25%-99.25%-314.61%-192.73%-12.94%-32.85%-8.06%0.47%
Net Income (Continuing)
-15.96M42.82M-536K-1.07M-4.43M-12.96M-14.64M-19.45M-21.02M-20.23M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
-0.53▲ 0%
1.20▲ 326.4%
-0.10▼ 107.9%
-0.14▼ 46.9%
-0.56▼ 300.0%
-1.59▼ 183.9%
-0.72▲ 54.7%
-0.73▼ 1.4%
-0.62▲ 15.1%
-0.50▲ 0%
EPS Growth %
-130.29%326.42%-107.94%-46.9%-300%-183.93%54.72%-1.39%15.07%22.97%
EPS (Basic)
-0.531.20-0.10-0.14-0.56-1.59-0.72-0.73-0.62-
Diluted Shares Outstanding
30.39M35.78M8.17M8.17M7.81M8.17M20.33M26.65M33.71M40.59M
Basic Shares Outstanding
30.39M35.78M8.17M8.17M7.81M8.17M20.33M26.65M33.71M40.59M
Dividend Payout Ratio
----------

BEAT Balance Sheet

HeartBeam, Inc. (BEAT) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
90.11M146.66M7K51K14M4.04M16.82M2.77M4.68M2.44M
Cash & Short-Term Investments
36.02M80.89M5K24K13.19M3.59M16.19M2.38M4.38M2.04M
Cash Only
36.02M80.89M5K24K13.19M3.59M16.19M2.38M4.38M2.04M
Short-Term Investments
0000000000
Accounts Receivable
38.49M52.63M00000000
Days Sales Outstanding
48.9848.09--------
Inventory
5.33M7.32M000000103K133K
Days Inventory Outstanding
17.0117.94-------897.29
Other Current Assets
10.27M5.82M00000393K202K263K
Total Non-Current Assets
434.45M440.14M00806K0306K506K1.16M1.49M
Property, Plant & Equipment
49.19M48.38M56.38M000256K450K1.1M1.44M
Fixed Asset Turnover
5.83x8.26x-------0.00x
Goodwill
223.1M238.81M301.32M0000000
Intangible Assets
141.71M129.65M129.6M0000000
Long-Term Investments
00000000056K
Other Non-Current Assets
2.77M3.32M-499.92M0806K050K56K56K56K
Total Assets
524.56M▲ 0%
586.8M▲ 11.9%
7K▼ 100.0%
51K▲ 628.6%
14M▲ 27347.1%
4.04M▼ 71.1%
17.13M▲ 324.1%
3.28M▼ 80.9%
5.84M▲ 78.4%
3.93M▲ 0%
Asset Turnover
0.55x0.68x-------0.00x
Asset Growth %
163.62%11.86%-100%628.57%27347.06%-71.15%324.14%-80.88%78.36%-76.23%
Total Current Liabilities
50.95M49.62M354K4.84M588K1.67M1.19M1.62M3.24M3.29M
Accounts Payable
13.23M18.16M24.2M474K587K1.66M556K531K00
Days Payables Outstanding
42.244.48-------6.98K
Short-Term Debt
2.05M5.13M42K4.29M000000
Deferred Revenue (Current)
4.3M3.08M-3100000000
Other Current Liabilities
31.38M23.26M-23.89M52K00636K03.24M3.29M
Current Ratio
1.77x2.96x0.02x0.01x23.81x2.43x14.09x1.71x1.45x0.74x
Quick Ratio
1.66x2.81x0.02x0.01x23.81x2.43x14.09x1.71x1.41x0.70x
Cash Conversion Cycle
23.821.54--------6.08K
Total Non-Current Liabilities
223.9M226.69M3.38M0000000
Long-Term Debt
197.31M193.42M3.38M0000000
Capital Lease Obligations
0000000000
Deferred Tax Liabilities
0000000000
Other Non-Current Liabilities
26.6M33.27M00000000
Total Liabilities
274.86M276.32M3.73M4.84M588K1.67M1.19M1.62M3.24M3.29M
Total Debt
199.36M198.55M3.42M4.29M000000
Net Debt
163.33M117.66M3.42M4.27M-13.19M-3.59M-16.19M-2.38M-4.38M-2.04M
Debt / Equity
0.80x0.64x-------0.00x
Debt / EBITDA
3.02x1.60x--------0.00x
Net Debt / EBITDA
2.48x0.95x-------0.10x
Interest Coverage
-1.12x5.40x-1.21x-2.81x-1.06x-196.39x----
Total Equity
250.76M▲ 0%
310.49M▲ 23.8%
-3.73M▼ 101.2%
-4.79M▼ 28.4%
13.41M▲ 380.3%
2.37M▼ 82.3%
15.94M▲ 571.3%
1.65M▼ 89.6%
2.6M▲ 57.4%
635K▲ 0%
Equity Growth %
80.51%23.82%-101.2%-28.39%380.25%-82.3%571.31%-89.62%57.38%-177.7%
Book Value per Share
8.258.68-0.46-0.591.720.290.780.060.080.02
Total Shareholders' Equity
250.76M310.49M-3.73M-4.79M13.41M2.37M15.94M1.65M2.6M635K
Common Stock
32K33K1K01K1K3K3K4K4K
Retained Earnings
-158.68M-115.86M-3.73M-4.8M-9.22M-22.19M-36.83M-56.27M-77.29M-81.99M
Treasury Stock
0000000000
Accumulated OCI
-71.9M-67.2M00000000
Minority Interest
0000000000

BEAT Cash Flow Statement

HeartBeam, Inc. (BEAT) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
23.78M72.75M-218K-600K-3.23M-9.95M-12.09M-14.47M-13.99M-13.12M
Operating CF Margin %
8.29%18.21%--------
Operating CF Growth %
-38.79%205.89%-100.3%-175.23%-438.33%-207.99%-21.56%-19.66%3.34%56.75%
Net Income
-15.96M42.82M-536K-1.07M-4.43M-12.96M-14.64M-19.45M-21.02M-20.23M
Depreciation & Amortization
28.56M40.17M000007K40K57K
Stock-Based Compensation
7.68M0010K192K1.12M3.21M4.3M5.15M4.04M
Deferred Taxes
6.05M-2.29M00000000
Other Non-Cash Items
-13.65M-75.09M242K276K2.14M000226K1.44M
Working Capital Changes
11.1M57.88M76K182K-1.14M1.89M-662K671K1.61M1.57M
Change in Receivables
-19.1M-40.92M00000000
Change in Inventory
665K-1.99M000000-103K-30K
Change in Payables
-9.62M3.76M0001.53M-471K428K00
Cash from Investing
-177.19M-28.85M0000-256K-201K-600K2.91M
Capital Expenditures
-13.7M-24.64M0000-256K-201K-600K-846K
CapEx % of Revenue
4.78%6.17%--------
Acquisitions
0000000000
Investments
----------
Other Investing
-162.17M-4.21M00000000
Cash from Financing
166.46M601K206K619K16.4M350K24.99M866K16.59M7.86M
Debt Issued (Net)
00206K619K1.69M00000
Equity Issued (Net)
000014.71M348K24.99M730K16.59M-8.73M
Dividends Paid
0000000000
Share Repurchases
0000000000
Other Financing
166.46M601K0002K0136K016.59M
Net Change in Cash
12.97M▲ 0%
44.87M▲ 245.9%
-12K▼ 100.0%
19K▲ 258.3%
13.17M▲ 69205.3%
-9.6M▼ 172.9%
12.64M▲ 231.7%
-13.81M▼ 209.2%
2M▲ 114.5%
-2.35M▲ 0%
Free Cash Flow
10.09M▲ 0%
48.11M▲ 377.0%
-218K▼ 100.5%
-600K▼ 175.2%
-3.23M▼ 438.3%
-9.95M▼ 208.0%
-12.35M▼ 24.1%
-14.67M▼ 18.8%
-14.59M▲ 0.6%
-13.97M▲ 0%
FCF Margin %
3.52%12.04%--------
FCF Growth %
-63.92%377.04%-100.45%-175.23%-438.33%-207.99%-24.14%-18.81%0.57%10.46%
FCF per Share
0.331.34-0.03-0.07-0.41-1.22-0.61-0.55-0.43-0.34
FCF Conversion (FCF/Net Income)
-1.49x1.70x0.41x0.56x0.73x0.77x0.83x0.74x0.67x0.69x
Interest Paid
0000000000
Taxes Paid
0000000000

BEAT Key Ratios

HeartBeam, Inc. (BEAT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
-8.19%15.26%-0.35%--102.68%-164.24%-159.89%-221.11%-987.32%-1034.04%
Return on Invested Capital (ROIC)
10.09%14.96%-0.1%------1648.02%
Gross Margin
60.11%62.7%--------
Net Margin
-5.56%10.72%--------
Debt / Equity
0.80x0.64x-------0.00x
Interest Coverage
-1.12x5.40x-1.21x-2.81x-1.06x-196.39x----
FCF Conversion
-1.49x1.70x0.41x0.56x0.73x0.77x0.83x0.74x0.67x0.69x
Revenue Growth
37.65%39.3%-100%-------
Related:BEAT Dividend History·BEAT Revenue History·BEAT Price History·BEAT P/E History·BEAT Financial Ratios·BEAT Institutional Holders

BEAT SEC Filings & Documents

HeartBeam, Inc. (BEAT) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 16, 2026·SEC

Material company update

Nov 21, 2025·SEC

Material company update

Jul 16, 2025·SEC

10-K Annual Reports

5
FY 2026

Mar 12, 2026·SEC

FY 2025

Mar 13, 2025·SEC

FY 2024

Mar 20, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 13, 2026·SEC

FY 2025

Nov 13, 2025·SEC

FY 2025

Aug 13, 2025·SEC

BEAT Frequently Asked Questions

HeartBeam, Inc. (BEAT) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

HeartBeam, Inc. (BEAT) grew revenue by 0.0% over the past year. Growth has been modest.

HeartBeam, Inc. (BEAT) reported a net loss of $20.2M for fiscal year 2025.

Dividend & Returns

HeartBeam, Inc. (BEAT) has a return on equity (ROE) of -987.3%. Negative ROE indicates the company is unprofitable.

HeartBeam, Inc. (BEAT) had negative free cash flow of $14.0M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in BEAT back in 2006?

Total return calculator · dividends reinvested · 20+ years of data

See returns →

How much would $100/month in BEAT be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →